An estimated 2.3 million individuals are living with multiple sclerosis (MS) worldwide. Approximately half of all individuals with MS experience changes in cognition such as impaired concentration, ...

Soluble α2δ-1 may restore brain balance and reverse schizophrenia deficits. Discover this potential therapeutic breakthrough.

Researchers at the MIT Media Lab have published a new study measuring what happens inside the brain when people use ChatGPT ...

How does APOE4 cause Alzheimer's? A new study identifies the Nell2 protein as the driver of neuron shrinkage and brain ...

The brain network that links thinking with movement, called SCAN, was first described by WashU Medicine researchers in 2023 and has been identified in a new study as the neurological basis of ...

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive memory loss, cognitive decline, and behavioral changes. The deficits linked to AD are known to result from the ...

A study reveals the SCAN brain network's potential to enhance Parkinson’s treatment through targeted non-invasive therapies.

The findings show that APOE4-induced Nell2 production alters neuron size and activity, contributing to Alzheimer’s risk. Suppressing Nell2 restored normal function, pointing to a potential early ...

Parkinson's disease, a progressive neurological disorder affecting more than 1 million people in the U.S. and more than 10 million globally, is characterized by debilitating symptoms such as tremors, ...